BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 22114139)

  • 1. MicroRNA alterations of pancreatic intraepithelial neoplasias.
    Yu J; Li A; Hong SM; Hruban RH; Goggins M
    Clin Cancer Res; 2012 Feb; 18(4):981-92. PubMed ID: 22114139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells.
    Prasad NB; Biankin AV; Fukushima N; Maitra A; Dhara S; Elkahloun AG; Hruban RH; Goggins M; Leach SD
    Cancer Res; 2005 Mar; 65(5):1619-26. PubMed ID: 15753353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma.
    Ryu JK; Hong SM; Karikari CA; Hruban RH; Goggins MG; Maitra A
    Pancreatology; 2010; 10(1):66-73. PubMed ID: 20332664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.
    du Rieu MC; Torrisani J; Selves J; Al Saati T; Souque A; Dufresne M; Tsongalis GJ; Suriawinata AA; Carrère N; Buscail L; Cordelier P
    Clin Chem; 2010 Apr; 56(4):603-12. PubMed ID: 20093556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms.
    Chang X; Yu C; Li J; Yu S; Chen J
    Int J Med Sci; 2017; 14(5):412-418. PubMed ID: 28539816
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.
    Kanno S; Nosho K; Ishigami K; Yamamoto I; Koide H; Kurihara H; Mitsuhashi K; Shitani M; Motoya M; Sasaki S; Tanuma T; Maguchi H; Hasegawa T; Kimura Y; Takemasa I; Shinomura Y; Nakase H
    Carcinogenesis; 2017 Apr; 38(4):425-431. PubMed ID: 28186267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer.
    Sutaria DS; Jiang J; Azevedo-Pouly AC; Wright L; Bray JA; Fredenburg K; Liu X; Lu J; Torres C; Mancinelli G; Grippo PJ; Coppola V; Schmittgen TD
    Sci Rep; 2019 Jul; 9(1):11147. PubMed ID: 31367007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-4653-3p overexpression is associated with a poor prognosis of pancreatic ductal adenocarcinoma via HIPK2 downregulation.
    Hirabayashi K; Miyazawa M; Takanashi Y; Morimachi M; Kawanishi A; Saika T; Nakagohri T; Nakamura N
    Sci Rep; 2022 Oct; 12(1):17927. PubMed ID: 36289359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.
    Quattrochi B; Gulvady A; Driscoll DR; Sano M; Klimstra DS; Turner CE; Lewis BC
    Oncotarget; 2017 May; 8(22):35902-35918. PubMed ID: 28415794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Where and when does pancreatic carcinoma start?
    Lüttges J; Hahn S; Klöppel G
    Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
    Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
    Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
    Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
    Nakata K; Ohuchida K; Mizumoto K; Kayashima T; Ikenaga N; Sakai H; Lin C; Fujita H; Otsuka T; Aishima S; Nagai E; Oda Y; Tanaka M
    Surgery; 2011 Nov; 150(5):916-22. PubMed ID: 22018284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas.
    Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A
    Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Qian J; Niu J; Li M; Chiao PJ; Tsao MS
    Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
    Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
    Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma.
    Dobre M; Herlea V; Vlăduţ C; Ciocîrlan M; Balaban VD; Constantinescu G; Diculescu M; Milanesi E
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.